Cuba Drug Policy: Las Tunas unveiled Cuba’s first provincial Drug Observatory, built from a toxicology training push that began in 2023, aiming to track substance abuse and improve prevention across three working networks. CBD Product Science: Trait Biosciences spotlighted CBD82S™ for anxiety-like behavior reduction in mice, pitching water-soluble CBD as a way to improve absorption and simplify dosing. Medical Cannabis Rules (Nebraska): Nebraska Gov. Jim Pillen and AG Mike Hilgers approved medical cannabis regulations that ban smoking/combustion/vaping and cap THC limits, while restricting purchase amounts and limiting dispensaries statewide. Hemp Legal Win (Alabama): A Foley hemp store beat the state after a case tied to seized hemp products and cash was dismissed with prejudice, with the court ruling against the state’s drug-activity claims. Cannabis Market Education (New York): A University at Buffalo study found many New Yorkers use cannabis but don’t fully understand required labeling like ingredients, dosages, and whether products are legally produced. Cannabinoid R&D (Korea): HLB Life Science R&D joined a government-backed pipeline project expanding beyond CBD into minor cannabinoids for medical hemp development. Therapeutics Deal (Epilepsy): Splash Beverage Group secured exclusive global licensing for CannEpil®, a cannabinoid-based investigational therapy for drug-resistant epilepsy, with European patient access and U.S. development plans. Workplace Drug Testing Tech: Cannabix Technologies announced breath testing detection of cocaine and benzoylecgonine, expanding beyond THC for multi-drug workplace and law-enforcement use. Industry Labor (Missouri): Cannabis workers in Missouri scored union wins, including a first collective bargaining contract for dispensary workers. Regulatory Tension (Oregon): Oregon regulators proposed steep psilocybin fee hikes, drawing warnings that the industry may not survive the cost increases.